Curis Inc CRIS
$4.02
-8.84%
at last close
Market Cap$7.83 million
P/E Ratio—
Div Yield—
Volume70.0K
52-Week Range
$3.61$40.28
Key Stats
- Today's Range
- $3.96 – $4.35
- 50-Day Range
- $3.61 – $11.41
- 52-Week Range
- $3.61 – $40.28
- Volume
- 70K shs
- Average Volume
- 348K shs
- Market Cap
- $7.83 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 0.62
- Price / Sales
- 1.11
Short Interest
- Short Interest
- 73.01%
- Days to Cover
- 1.12
Financials (TTM)
- Revenue
- $7.06 million
- Net Income
- $-21,165,000
- Net Margin
- -299.66%
- Return on Equity
- -166.56%
- Debt-to-Equity
- —
About Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Related Stocks
Compare head-to-head: CRIS vs AMGN·CRIS vs HALO·CRIS vs RGEN·CRIS vs IMVT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.